Avoro Ventures Adds Sara Nayeem, MD, as a Partner

NEW YORK--(BUSINESS WIRE)-- Avoro Ventures announced today that Sara Nayeem, MD, has joined the firm as a Partner, focused on its venture capital investment efforts.

Dr. Nayeem joins Avoro Ventures after 12 years with New Enterprise Associates, Inc. (NEA), where she was a Partner in the firm’s biopharma investment practice serving on numerous company boards, in addition to providing support to fundraising, recruiting, and diversity and mentoring initiatives. She will source and manage private market investments within the biotechnology sector spanning early stage to late stage and cross-over, joining Behzad Aghazadeh, PhD, Managing Partner of Avoro Ventures and Avoro Capital Advisors, and Dr. Garheng Kong, Avoro Ventures Advisory Partner.

About Avoro Ventures

Avoro Ventures is an affiliated company of Avoro Capital Advisors, an SEC-registered investment manager based in New York City, with over $5.4 billion in capital primarily focused on life sciences and biotechnology.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210218005274/en/

Andy Merrill
Prosek Partners
[email protected]
917-622-1252

Source: Avoro Ventures

You May Also Be Interested In

• SEC proposes new rules for crypto asset investment contracts
• SEC proposes rules to create regime for some crypto contracts
• Xylem names Andrea van der Berg as CFO, effective Sept. 2026